| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
A 37-year-old female diagnosed with attention-deficit hyperactive disorder (ADHD) presented for her annual Adderall (amphetamine and d-amphetamine) compliance testing visit and prescription refill.
The confirmatory amphetamine urine test results were as follows:
|
Drug |
Result |
Cut-off |
|
Amphetamine |
15,988 ng/mL |
< 25 ng/mL |
|
Methamphetamine |
58 ng/mL |
< 25 ng/mL |
|
Phentermine |
negative |
< 25 ng/mL |
|
MDA |
negative |
< 25 ng/mL |
|
MDMA |
negative |
< 25 ng/mL |
|
Pseudoephedrine/ephedrine |
negative |
< 25 ng/mL |
This patient also had a history of polysubstance abuse (methamphetamines and cocaine); however, self-reported as being in remission for a number of years. Based on the results, the provider was concerned that the patient had relapsed and started abusing methamphetamine again.
This quiz is no longer available. |
Sarah Delaney, Ph.D. Fellow, Clinical Chemistry Mayo Clinic |
 |
Loralie Langman, Ph.D. Consultant, Clinical Biochemistry Mayo Clinic Professor of Laboratory Medicine and Pathology Mayo Clinic College of Medicine and Science |
 |
Paul Jannetto, Ph.D. Consultant, Clinical Biochemistry Mayo Clinic Associate Professor of Laboratory Medicine and Pathology Mayo Clinic College of Medicine and Science |
